Radoje (Rade) Drmanac is one of the founders of the field of Genomics. Currently he serves as Senior VP of BGI (Shenzhen, China) and Director and Chief Scientific Officer (CSO) at Complete Genomics, Inc. (CGI), now a BGI-owned company, that he co-founded with Cliff Reid in 2005 to develop technologies for efficient and accurate individual genome sequencing (Science 2010; Nature 2012, Science 2012). He invented and led the development of massively parallel DNA sequencing using DNA nanoarrays, ligation-based DNA sequencing, long fragment read and other technologies. Earlier, in 1994, he co-founded Hyseq (later Nuvelo and now ARCA), and served as Director until 2001. As SVP of research and CSO, he led Hyseq’s effort to discover and patent thousands of novel genes for its drug development pipeline. Prior to Hyseq, he was a group leader at Argonne National Labs (1991-1994) as part of DOE Human Genome Project. He completed his postdoctoral studies in 1990 at ICRF in London. He received his Ph.D. in Molecular Biology in 1988 at Belgrade University, Serbia, for the conception and pioneering development of the first massively parallel sequencing technology using DNA microarrays (Genomics 1989; Sci. Yugoslavica 1990, Science 1993). At the same university he received BS (1981) and MS (1985) degrees in Molecular Biology. Since 1987, Dr. Drmanac received over 30 patents and over $20M in government grants for the development of advanced genome sequencing technologies.